Non-invasive detection of hepatic amyloidosis: FibroScan, a new tool

Amyloid

Volumn 18, Issue 1, 2011, Pages 19-24

  Loustaud Ratti, Véronique ^a   Cypierre, Anne ^a   Rousseau, Annick ^b   Yagoubi, Fatima ^a   Abraham, Julie ^a   Fauchais, Anne Laure ^a   Carrier, Paul ^a   Lefebvre, Annie ^a   Bordessoule, Dominique ^a   Vidal, Elisabeth ^a   Sautereau, Denis ^a   Jaccard, Arnaud ^a  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

^b Univ Limoges   (France)

Author keywords

AL amyloidosis; FibroScan; hepatic amyloidosis; transient elastometry

Indexed keywords

AMYLOID;

AMYLOIDOSIS; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; FIBROSCAN; HEART DISEASE; HEPATITIS C; HUMAN; LIVER AMYLOIDOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AMYLOIDOSIS; ELASTICITY; ELASTICITY IMAGING TECHNIQUES; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER DISEASES; PLAQUE, AMYLOID;

EID: 79751514798     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2010.543443     Document Type: Article

References (20)

1. Buck FS, Koss MN. Hepatic amyloidosis: morphologic differences between systemic AL and AA types. Hum Pathol 1991;22:904-907.
2. Gertz MA, Kyle RA. Hepatic amyloidosis (primary [AL], immunoglobulin light chain): the natural history in 80 patients. Am J Med 1988;85:73-80.
3. Park MA, Mueller PS, Kyle RA, Larson DR, Plevak MF, Gertz MA. Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients. Medicine (Baltimore) 2003;82:291-298. (Pubitemid 37229464)
4. Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, Merlini G, Moreau P, Ronco P, Sanchorawala V, Sezer O, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol 2005;79:319-328. (Pubitemid 41098849)
5. Ebert EC, Nagar M. Gastrointestinal manifestations of amyloidosis. Am J Gastroenterol 2008;103:776-787. (Pubitemid 351405997)
6. Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008;48: 835-847.
7. Marcellin P, Ziol M, Bedossa P, Douvin C, Poupon R, De Lédinghen V, Beaugrand M. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009;29:242-247.
8. Corpechot C, El Naggar A, Poujol-Robert A, Ziol M, Wendum D, Chazouillères O, de Lédinghen V, Dhumeaux D, Marcellin P, Beaugrand M, et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 2006;43:1118-1124. (Pubitemid 43724636)
9. Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, Herrmann E. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008;134:960-974.
10. Coco B, Oliveri F, Maina AM, Ciccorossi P, Sacco R, Colombatto P, Bonino F, Brunetto MR. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepatol 2007;14:360-369. (Pubitemid 46587854)
11. Arena U, Vizzutti F, Corti G, Ambu S, Stasi C, Bresci S, Moscarella S, Boddi V, Petrarca A, Laffi G, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008;47:380-384. (Pubitemid 351280705)
12. Millonig G, Reimann FM, Friedrich S, Fonouni H,Mehrabi A, Büchler MW, Seitz HK, Mueller S. Extrahepatic Cholestasis increases liver stiffness irrespective of fibrosis. Hepatology 2008;48:1718-1723.
13. Millonig G, Friedrich S, Adolf S, Fonouni H, Golriz M, Mehrabi A, Stiefel P, Pöschl G, Büchler MW, Seitz HK, et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol 2010;52:206-210.
14. Lanzi A, Gianstefani A, Mirarchi MG, Pini P, Conti F, Bolondi L. Liver AL amyloidosis as a possible cause of high liver stiffness values. Eur J Gastroenterol Hepatol 2010;22: 895-897.
15. Wall J, Solomon A. Flow cytometric characterization of amyloid fibrils. Methods Enzymol 1999;309:460-466. (Pubitemid 29446465)
16. Gosink BB, Leymaster CE. Ultrasonic determination of hepatomegaly. J Clin Ultrasound 1981;9:37-44.
17. Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, Christidis C, Ziol M, Poulet B, Kazemi F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003;29:1705-1713. (Pubitemid 38091720)
18. Yood RA, Skinner M, Rubinow A, Talarico L, Cohen AS. Bleeding manifestations in 100 patients with amyloidosis. JAMA 1983;249:1322-1324. (Pubitemid 13147782)
19. Kos CA, Ward JE, Malek K, Sanchorawala V, Wright DG, O'Hara C, et al. Association of acquired Von Willebrand syndrome with AL amyloidosis. Am J Hematol 2007;82:363-367. (Pubitemid 46651139)
20. Girnius S, Seldin DC, Skinner M, Finn KT, Quillen K, Doros G, et al. Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease. Haematologica 2009;94:1029-1032.